Piotr Ruchała

3.8k total citations · 1 hit paper
61 papers, 3.1k citations indexed

About

Piotr Ruchała is a scholar working on Molecular Biology, Microbiology and Hematology. According to data from OpenAlex, Piotr Ruchała has authored 61 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 15 papers in Microbiology and 12 papers in Hematology. Recurrent topics in Piotr Ruchała's work include Antimicrobial Peptides and Activities (15 papers), Trace Elements in Health (10 papers) and Iron Metabolism and Disorders (10 papers). Piotr Ruchała is often cited by papers focused on Antimicrobial Peptides and Activities (15 papers), Trace Elements in Health (10 papers) and Iron Metabolism and Disorders (10 papers). Piotr Ruchała collaborates with scholars based in United States, United Kingdom and Netherlands. Piotr Ruchała's co-authors include Alan J. Waring, Elizabeta Nemeth, Tomas Ganz, Robert I. Lehrer, Mei Hong, Yongchao Su, Grace Jung, Gloria C. Preza, Emilio Ramos and Ewa D. Micewicz and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Blood.

In The Last Decade

Piotr Ruchała

61 papers receiving 3.0k citations

Hit Papers

Mitochondrial Dysfunction, Through Impaired Autophagy, Le... 2017 2026 2020 2023 2017 50 100 150 200 250

Peers

Piotr Ruchała
Margaret A. Holmes United States
Wen‐Chao Song United States
J Choay France
Penelope E. Stein United Kingdom
Toni Antalis United States
W. Breuer Germany
Piotr Ruchała
Citations per year, relative to Piotr Ruchała Piotr Ruchała (= 1×) peers Peter Schulz‐Knappe

Countries citing papers authored by Piotr Ruchała

Since Specialization
Citations

This map shows the geographic impact of Piotr Ruchała's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Piotr Ruchała with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Piotr Ruchała more than expected).

Fields of papers citing papers by Piotr Ruchała

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Piotr Ruchała. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Piotr Ruchała. The network helps show where Piotr Ruchała may publish in the future.

Co-authorship network of co-authors of Piotr Ruchała

This figure shows the co-authorship network connecting the top 25 collaborators of Piotr Ruchała. A scholar is included among the top collaborators of Piotr Ruchała based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Piotr Ruchała. Piotr Ruchała is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Micewicz, Ewa D., Kwanghee Kim, Keisuke S. Iwamoto, et al.. (2017). 4-(Nitrophenylsulfonyl)piperazines mitigate radiation damage to multiple tissues. PLoS ONE. 12(7). e0181577–e0181577. 13 indexed citations
2.
Riahi, Rana, Ekambaram Ganapathy, Hao Shao, et al.. (2016). Allosteric heat shock protein 70 inhibitors block hepatitis C virus assembly. International Journal of Antimicrobial Agents. 47(4). 289–296. 27 indexed citations
3.
Micewicz, Ewa D., Josephine A. Ratikan, Alan J. Waring, et al.. (2015). Lipid-conjugated Smac analogues. Bioorganic & Medicinal Chemistry Letters. 25(20). 4419–4427. 2 indexed citations
4.
Micewicz, Ewa D., Omar Bahattab, Gary B. Willars, et al.. (2015). Small lipidated anti-obesity compounds derived from neuromedin U. European Journal of Medicinal Chemistry. 101. 616–626. 15 indexed citations
5.
Ruchała, Piotr, Alan J. Waring, Chun‐Ling Jung, et al.. (2014). Structural characterization of the HSP70 interaction domain of the hepatitis C viral protein NS5A. Virology. 475. 46–55. 14 indexed citations
6.
Cole, Amy L., Piotr Ruchała, Alan J. Waring, et al.. (2013). A Compensatory Mutation Provides Resistance to Disparate HIV Fusion Inhibitor Peptides and Enhances Membrane Fusion. PLoS ONE. 8(2). e55478–e55478. 12 indexed citations
7.
Micewicz, Ewa D. & Piotr Ruchała. (2013). Inhibitors of HIV-1 Entry. Current Pharmaceutical Design. 19(10). 1784–1799. 7 indexed citations
8.
Yount, Nannette Y., S. Cohen, Deborah Kupferwasser, et al.. (2011). Context Mediates Antimicrobial Efficacy of Kinocidin Congener Peptide RP-1. PLoS ONE. 6(11). e26727–e26727. 15 indexed citations
9.
Arumugaswami, Vaithilingaraja, et al.. (2011). A cell-permeable hairpin peptide inhibits hepatitis C viral nonstructural protein 5A–mediated translation and virus production. Hepatology. 55(6). 1662–1672. 17 indexed citations
10.
Cole, Alexander M., Dorothy L. Patton, Lisa C. Rohan, et al.. (2010). The Formulated Microbicide RC-101 Was Safe and Antivirally Active Following Intravaginal Application in Pigtailed Macaques. PLoS ONE. 5(11). e15111–e15111. 133 indexed citations
11.
Micewicz, Ewa D., Amy L. Cole, Chun‐Ling Jung, et al.. (2010). Grifonin-1: A Small HIV-1 Entry Inhibitor Derived from the Algal Lectin, Griffithsin. PLoS ONE. 5(12). e14360–e14360. 68 indexed citations
12.
Venkataraman, Nitya, Amy L. Cole, Piotr Ruchała, et al.. (2009). Reawakening Retrocyclins: Ancestral Human Defensins Active Against HIV-1. PLoS Biology. 7(4). e1000095–e1000095. 72 indexed citations
13.
Lehrer, Robert I., Grace Jung, Piotr Ruchała, et al.. (2009). Multivalent Binding of Carbohydrates by the Human α-Defensin, HD5. The Journal of Immunology. 183(1). 480–490. 76 indexed citations
14.
Sang, Yongming, Piotr Ruchała, Robert I. Lehrer, et al.. (2009). Antimicrobial Host Defense Peptides in an Arteriviral Infection: Differential Peptide Expression and Virus Inactivation. Viral Immunology. 22(4). 235–242. 24 indexed citations
15.
Navab, Mohamad, Piotr Ruchała, Alan J. Waring, et al.. (2009). A novel method for oral delivery of apolipoprotein mimetic peptides synthesized from all L-amino acids. Journal of Lipid Research. 50(8). 1538–1547. 50 indexed citations
16.
Su, Yongchao, Tim Doherty, Alan J. Waring, Piotr Ruchała, & Mei Hong. (2009). Roles of Arginine and Lysine Residues in the Translocation of a Cell-Penetrating Peptide from13C,31P, and19F Solid-State NMR. Biochemistry. 48(21). 4587–4595. 133 indexed citations
17.
Azimov, Rustam, Natalia Abuladze, Pakan Sassani, et al.. (2008). G418-mediated ribosomal read-through of a nonsense mutation causing autosomal recessive proximal renal tubular acidosis. American Journal of Physiology-Renal Physiology. 295(3). F633–F641. 12 indexed citations
18.
Salvatore, Mirella, Adolfo Garcı́a-Sastre, Piotr Ruchała, et al.. (2007). α‐Defensin Inhibits Influenza Virus Replication by Cell‐Mediated Mechanism(s). The Journal of Infectious Diseases. 196(6). 835–843. 121 indexed citations
19.
Ruchała, Piotr, Györgyi Váradi, Tetsuya Ishino, et al.. (2004). Cyclic peptide interleukin 5 antagonists mimic CD turn recognition epitope for receptor α. Biopolymers. 73(5). 556–568. 9 indexed citations
20.
Ruchała, Piotr, et al.. (2003). Synthesis, conformation, and immunosuppressive activity of CLX and its analogues. Biopolymers. 70(4). 497–511. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026